v3.25.2
Commitments and Contingencies (Details Narrative) - USD ($)
6 Months Ended
Oct. 11, 2023
Oct. 05, 2023
Jun. 30, 2025
Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]        
Reimbursement of expenses     $ 690,000  
Underwriters [Member]        
Subsidiary, Sale of Stock [Line Items]        
Proceeds from issuance initial public offering $ 9,000,000      
Shares issued     69,000 69,000
Shares outstanding     69,000 69,000
Over-Allotment Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Vesting period   45 days    
Stock issued during period, shares, new issues   900,000    
Share purchased 900,000      
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Proceeds from issuance initial public offering $ 69,000,000      
Percentage of underwriting discount 2.00%      
Deferred fee, percentage 3.50%      
IPO [Member] | Underwriting Agreement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Proceeds from issuance initial public offering $ 2,415,000      
IPO [Member] | Underwriters [Member]        
Subsidiary, Sale of Stock [Line Items]        
Proceeds from issuance initial public offering 1,380,000      
Reimbursement of expenses $ 690,000